Inoviv

Active

LC-MS biomarker panels for drug developers.

What it does

Inoviv delivers custom, multiplexed LC-MS proteomics panels with absolute quantification and end-to-end support for biomarker discovery and validation. These workflows yield high reproducibility and accuracy—helping pharmaceutical teams accelerate development and reduce risk in clinical programs.

Its site says now · captured 2026-08-23

Home - Inoviv

Multiplexed & quantitative LC-MS proteomics with end-to-end support for drug discovery & development using rapid, robust biomarker analysis